HK1029143A1 - Methods of evaluating transplant rejection - Google Patents

Methods of evaluating transplant rejection

Info

Publication number
HK1029143A1
HK1029143A1 HK00108485A HK00108485A HK1029143A1 HK 1029143 A1 HK1029143 A1 HK 1029143A1 HK 00108485 A HK00108485 A HK 00108485A HK 00108485 A HK00108485 A HK 00108485A HK 1029143 A1 HK1029143 A1 HK 1029143A1
Authority
HK
Hong Kong
Prior art keywords
methods
transplant rejection
evaluating
evaluating transplant
perforin
Prior art date
Application number
HK00108485A
Other languages
English (en)
Inventor
Terry B Strom
Lauro Vasconcellos
Manikkam Suthanthiran
Original Assignee
Beth Israel Hospital
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital, Cornell Res Foundation Inc filed Critical Beth Israel Hospital
Publication of HK1029143A1 publication Critical patent/HK1029143A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transplanting Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK00108485A 1997-09-24 2000-12-28 Methods of evaluating transplant rejection HK1029143A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/937,063 US6187534B1 (en) 1997-09-24 1997-09-24 Methods of evaluating transplant rejection
PCT/US1998/019549 WO1999015700A1 (en) 1997-09-24 1998-09-22 Methods of evaluating transplant rejection

Publications (1)

Publication Number Publication Date
HK1029143A1 true HK1029143A1 (en) 2001-03-23

Family

ID=25469437

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00108485A HK1029143A1 (en) 1997-09-24 2000-12-28 Methods of evaluating transplant rejection

Country Status (10)

Country Link
US (1) US6187534B1 (xx)
EP (1) EP1015639B1 (xx)
JP (1) JP2001517459A (xx)
AT (1) ATE354674T1 (xx)
AU (1) AU9493198A (xx)
CA (1) CA2304159C (xx)
DE (1) DE69837151T2 (xx)
ES (1) ES2280103T3 (xx)
HK (1) HK1029143A1 (xx)
WO (1) WO1999015700A1 (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104371A1 (en) * 1997-09-24 2003-06-05 Strom Terry B. Methods of evaluating transplant rejection
US6187534B1 (en) 1997-09-24 2001-02-13 Cornell Research Foundation, Inc. Methods of evaluating transplant rejection
US20070082356A1 (en) * 1997-09-24 2007-04-12 Cornell Research Foundation Inc., a New York, NY corporation Methods of evaluating transplant rejection
GB9925210D0 (en) * 1999-10-25 1999-12-22 Reneuron Ltd Identification of cells for transplantation
US6465215B1 (en) 1999-12-14 2002-10-15 Reneuron Limited Identification of cells for transplantation
US6900015B2 (en) * 2000-04-24 2005-05-31 Beth Israel Deaconess Medical Center, Inc. Measurement of protective genes in allograft rejection
EP1170589A1 (en) * 2000-06-05 2002-01-09 Stichting Sanquin Bloedvoorziening Method for histocompatibility testing
EP1334113A4 (en) * 2000-10-20 2007-08-08 Expression Diagnostics Inc EVALUATION OF LEUCOCYTAIRE EXPRESSION LEVEL
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) * 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
WO2003027242A2 (en) * 2001-09-24 2003-04-03 Duke University Fas ligand
US20030224422A1 (en) * 2002-04-08 2003-12-04 St. Jude Children's Research Hospital, Inc. Pre-and post therapy gene expression profiling to identify drug targets
EP1532278B1 (en) * 2002-08-22 2012-02-22 Novartis AG Diagnosis of chronic rejection
AU2003275363A1 (en) * 2002-10-01 2004-04-23 The Johns Hopkins University Use of biomarkers for detecting acute renal transplant rejection
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
JP4316617B2 (ja) * 2003-12-03 2009-08-19 ノバルティス アクチエンゲゼルシャフト 移植片拒絶反応のバイオマーカー
US8053182B2 (en) 2004-01-30 2011-11-08 The Trustees Of The University Of Pennsylvania Predictors of transplant rejection determined by peripheral blood gene-expression profiling
JP2006014722A (ja) * 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
GB0419728D0 (en) * 2004-09-06 2004-10-06 Novartis Ag Organic compounds
WO2006029184A2 (en) * 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
EP1850130B1 (en) * 2005-01-13 2011-11-02 Keio University Gene markers and utilzation of the same
WO2006122295A2 (en) * 2005-05-11 2006-11-16 Expression Diagnostics, Inc. Methods of monitoring functional status of transplants using gene panels
EP1880220A2 (en) * 2005-05-13 2008-01-23 University Of Miami Molecular dissection of cellular responses to alloantigen or autoantigen in graft rejection and autoimmune disease
CA2648580A1 (en) * 2006-04-07 2008-05-02 Xdx, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
GB0607943D0 (en) 2006-04-21 2006-05-31 Novartis Ag Biomarkers for chronic transplant dysfunction
US7993832B2 (en) * 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
US20080131441A1 (en) * 2006-09-26 2008-06-05 Manikkam Suthanthiran Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection
WO2008140484A2 (en) * 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
CN103003442B (zh) 2009-03-13 2018-10-09 康奈尔大学 一种通过微小rna表达水平评估人同种异体移植物状况的方法
WO2011006119A2 (en) 2009-07-09 2011-01-13 The Scripps Research Institute Gene expression profiles associated with chronic allograft nephropathy
WO2011112719A1 (en) 2010-03-09 2011-09-15 Cornell University Methods and compositions to predict and detect acute rejection
WO2014074501A1 (en) * 2012-11-06 2014-05-15 Quest Diagnostics Investments Incorporated Molecular markers for diagnosis of acute cellular rejection and acute tubular necrosis
US9758828B2 (en) 2013-01-31 2017-09-12 Cornell University Methods to detect, treat and prevent acute cellular rejection in kidney allografts
US9982301B2 (en) 2014-01-07 2018-05-29 Cornell University Urine mRNA profile and acute dysfunction of kidney allograft
KR101501085B1 (ko) * 2014-05-02 2015-03-12 순천향대학교 산학협력단 돼지 췌장의 발달단계별 차이를 나타내는 단백질을 포함하는 이종기관이식 거부반응 검출을 위한 신규한 항원 및 이를 포함하는 검출용 키트
US11104951B2 (en) 2014-05-22 2021-08-31 The Scripps Research Institute Molecular signatures for distinguishing liver transplant rejections or injuries
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5213961A (en) 1989-08-31 1993-05-25 Brigham And Women's Hospital Accurate quantitation of RNA and DNA by competetitive polymerase chain reaction
US6187534B1 (en) 1997-09-24 2001-02-13 Cornell Research Foundation, Inc. Methods of evaluating transplant rejection

Also Published As

Publication number Publication date
EP1015639A1 (en) 2000-07-05
AU9493198A (en) 1999-04-12
US6187534B1 (en) 2001-02-13
DE69837151T2 (de) 2008-01-03
ATE354674T1 (de) 2007-03-15
CA2304159C (en) 2012-07-10
WO1999015700A1 (en) 1999-04-01
JP2001517459A (ja) 2001-10-09
DE69837151D1 (de) 2007-04-05
EP1015639B1 (en) 2007-02-21
CA2304159A1 (en) 1999-04-01
ES2280103T3 (es) 2007-09-01

Similar Documents

Publication Publication Date Title
HK1029143A1 (en) Methods of evaluating transplant rejection
EP2287608A3 (en) Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
NZ601022A (en) Diagnosis and treatment of cancer using anti-ereg antibody
DE69823347D1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
Ilander et al. Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-α monotherapy
WO2005123779A3 (en) Antibodies binding to cd34+/cd36+ fetal but not to adult cells
Watanabe et al. A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood
EP2354253A3 (en) Method for non-invasive prenatal diagnosis
WO2006060265A3 (en) Methods and systems for prognosis and treatment of solid tumors
EP1687283A4 (en) PROCESS AND COMPOSITION FOR DETERMINING FK 506
HUP0002038A2 (hu) Génszekvenálási eszközök és eljárások
WO2002043758A3 (en) Uses of mammalian genes and related reagents
MXPA06014175A (es) Diagnostico o pronostico del curso del cancer de mama.
WO2005038041A3 (en) Direct nucleic acid detection in bodily fluids
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
WO2009052159A3 (en) Methods for selecting active agents for cancer treatment
WO2004019037A3 (de) Verfahren zum untersuchen von korperflussikeiten auf krebszellen sowie entsprechende analysekits
MXPA05014220A (es) Genes regulados en cancer ovarico como objetivos de pronostico y terapeuticos.
WO2005036127A3 (en) Methods and compositions for identifying target cell cytolytic lymphocytes in a sample
ATE404676T1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
ATE205600T1 (de) Leukozytadhaesiontest
WO2006132983A3 (en) Differential expression of molecules associated with vascular disease risk
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
Mishra et al. PD1+ TIGIT+ 2B4+ KLRG1+ Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20180921